Interpretation of the Results of the MINDACT Study and Consequent Recommendations in the Updated ASCO Clinical Practice Guideline.

作者信息

Lange Stefan, Scheibler Fueloep, Fleer Daniel, Windeler Juergen

机构信息

Stefan Lange, Fueloep Scheibler, Daniel Fleer, and Juergen Windeler, Institute for Quality and Efficiency in Health Care, Cologne, Germany.

出版信息

J Clin Oncol. 2018 Feb 1;36(4):429-430. doi: 10.1200/JCO.2017.75.9506. Epub 2017 Dec 11.

DOI:10.1200/JCO.2017.75.9506

PMID:29227725

Abstract

摘要

相似文献

Interpretation of the Results of the MINDACT Study and Consequent Recommendations in the Updated ASCO Clinical Practice Guideline.

J Clin Oncol. 2018 Feb 1;36(4):429-430. doi: 10.1200/JCO.2017.75.9506. Epub 2017 Dec 11.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.

J Clin Oncol. 2017 Aug 20;35(24):2838-2847. doi: 10.1200/JCO.2017.74.0472. Epub 2017 Jul 10.

Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.

J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5.

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations.

J Clin Oncol. 2016 Jul 1;34(19):2303-11. doi: 10.1200/JCO.2015.65.8609. Epub 2016 Mar 21.

The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice.

Histopathology. 2014 Apr;64(5):609-15. doi: 10.1111/his.12357. Epub 2014 Jan 31.

HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline.

Breast Cancer Res Treat. 2016 Feb;155(3):457-62. doi: 10.1007/s10549-016-3717-z. Epub 2016 Feb 19.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.

J Clin Oncol. 2018 Feb 1;36(4):428-429. doi: 10.1200/JCO.2017.75.3756. Epub 2017 Dec 11.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.

J Oncol Pract. 2016 Apr;12(4):384-9. doi: 10.1200/JOP.2016.010868. Epub 2016 Mar 8.

Is It Appropriate to Use the Result of an Unplanned, Exploratory, Nonstatistically Significant Subgroup Analysis to Support a Treatment Recommendation in an ASCO Treatment Guideline?

J Clin Oncol. 2020 Jan 1;38(1):102. doi: 10.1200/JCO.19.01687. Epub 2019 Nov 1.

Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. Health Services Research Committee of the American Society of Clinical Oncology.

J Clin Oncol. 1999 Nov;17(11):3676-81. doi: 10.1200/JCO.1999.17.11.3676.

引用本文的文献

Nomogram for the personalisation of radiotherapy treatments in breast cancer patients.

Breast. 2021 Dec;60:255-262. doi: 10.1016/j.breast.2021.11.004. Epub 2021 Nov 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验